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Georg JuckelAbstract
Depression is a common and hazardous mental disorder, which has been pathophysiologically associated with
alterations of neurocircuitries involving medial prefrontal cortex, hippocampus and thalamus. Recent progress in
computational neuroscience, particularly in the field of in silico psychopharmacology suggests the increasing
potential of mathematical modeling in providing insights on the dynamics of these neuronal networks, which in
turn may lead to further develop and clarify the present models of the pathophysiology of depression. Moreover,
computational approaches provide well-defined non-invasive frameworks for investigation of the clinically common
poly-pharmacological treatment strategies, which take us one step closer to the development of novel agents that
will potentially result in diagnostic and prognostic indicators to be used in individualized treatment strategies.
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Research of psychiatric diseases such as depression is
complicated thereby, that direct measurements are not
possible and validation models are available on a limited
basis.Main text
For the last two decades the prevalence of depression
has experienced an increase worldwide, starting with
10% at the end of the 80’s and is now counting 25%
(Wittchen et al. 2011). These are only partly absolute in-
creases because of the permanent rise of pressure to per-
form not only professionally but also privately. But there
is also a relative increase since in the past, many affected
people had received a different–more somatic–diagnosis
due to stigmatizations in classification of psychiatric
disorders. Depression is one of the most common and
hazardous diseases in the human population. Symptoms
of physical, mental and emotional ailment are considered
to be dramatic for both the affected person as well as for
the family. Furthermore, depression is potentially lethal
because of the considerably high suicide rates of above
10%, the estimatededly high number of unreported cases
of suicide and continuously prevailing agonizing, suicidalCorrespondence: georg.juckel@wkp-lwl.org
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revealed that depression is a longitudinal disease, encas-
ing one’s life story and development dynamically. We
have to assume that genetic and neurologic factors at
embryonic age and early childhood associated with critical
life events (like death, violence, separation, parting ex-
periences, trauma) trigger a mental condition in the af-
fected person, that lead to an outbreak of the depressive
disease when stress increases in the adult (e.g. at work
or due to private challenges) or when neurobiological
changes occur (e.g. during menopausal estrogen reduction
in females). Once appeared, depressive states frequently
recur in a lifetime.
However, most pivotal for these diseases is certainly the
neuronal correlate. Emanating from the monamine hypoth-
esis of the 60’s postulating a serotonin and noradrenalin
deficit in depressive patients, in the 70’s and 80’s percep-
tions evolved implying a change in the hypothalamic–
pituitary–adrenal axis. Findings of hypercortisolism in
many (but not all) patients attested to this claim. Many
pharmacologic drugs were developed but couldn’t be
used due to severe medical side effects.
In the last years, the concept of depression representing
a dysregulation in brain circuitries has been empirically se-
cured. In depression the brain is affected ubiquitary. There
is no global change of specific transmitters but there seem
to be dysregulating phenomena in certain brain circuitsn Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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prefrontal cortex as well as other brain regions, which are
of microstructured nature and can be found for example
in neuron populations such as the GABAergic interneu-
rons. The cause of these dysregulation is however still
mysterious. We assume that, apart from the hippocampus,
especially the medial prefrontal cortex plays a key role in
the pathophysiology of depression (Juckel et al. 1999;
Klein et al. 2010). These partly multifunctional changes as
well as the projection fibers are not illustratable with the
present imaging techniques such as structural magnetic
resonance imaging (MRI), functional magnetic resonance
imaging (fMRI), and positron emission tomography (PET).
Moreover, the present technologies do not allow an
adequate examination of the multi-scale interactions of
the alterations at neurocircuitry level with for instance
genetics of 5-HT transporters.
Discussion
Here we have to acknowledge clearly the domain of the
newly developing computational neuroscience, i.e. the
mathematical modeling of brain circuitries and their
changes. It is through mathematical modeling of neur-
onal networks, that we are able to monitor and alter
functional and dysfunctional states under systematic and
standardized conditions and that important conclusions
can be drawn upon the conditional structure of modified
brain circuits, e.g. in depression. In fact, it is imaginable
that computational neuroscience will lead to narrowing
down the question about the causative source depending
upon the integration of assumption of models relating to
one or two brain regions in order to examine them later
using human or animal experiments. This would include
the possibility of examining the operating mechanisms
and mightiness of the few more locally/regionally active
somato therapies in the treatment of depression, such as
deep brain stimulation, transcranial magnetic stimulation
or-with limitations-the EKT.
Furthermore, it is of vital importance to apply math-
ematical models to investigate the action of psychiatric
drugs. In the clinical routine we use antidepressants of
the SSRI type as a mono-therapy. We are insufficiently
informed about the regulatory characteristics of seroto-
nergic neurons in neuronal feedback cycles and the glu-
tamatergic projection fibers (of pyramidal cells) acting
with GABAergic interneurons. Furthermore, the impact
of the blockade of serotonin transporters particularly on
the somatodendritic autoreceptors 5-HT1A but also of
the terminal 5-HT1B receptors is still not clear (Jacobs
and Azmitia, 1992), which could be investigated by com-
putational approaches. Modeling such cascades would
greatly contribute to understanding not only the patho-
physiology of depression but also to comprehending
what operating mechanism lead to improvement ofdepression by antidepressants. Moreover, we can recognize
the potential of applying computational neuroscience to
psychopharmacology to optimize the treatment of de-
pression particularly with regard to the prevalence of
poly-pharmacological treatment strategies. For instance,
we know little about the interactions that are taking
place directly in the brain between antidepressants and
benzodiazepines or mood stabilizers such as lithium and
valproate. By modeling drug interaction interactions it is
possible to draw several conclusions from a specific ana-
tomic pathophysiological understanding with respect to
the mode of action as well as the cause of side effects.
Conclusions
In summary, in terms of psychiatry and depression in
particular, computational neuroscience represents a very
important column in future research and the entire field
of psychiatry and psychotherapy, especially biological
psychiatry would benefit from its outcomes.
Computational neuroscience describes a very plausible
and future-oriented non-invasive attempt to examine
and describe neuronal processes and their modifications
in psychiatric diseases like depression, psychoactive sub-
stances and psychotherapeutic strategies.
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